Hospital groups filed a lawsuit to block the Department of Health and Human Services from implementing a controversial pilot program that altered discount structures in the 340B drug pricing program.
Hospitals filed a lawsuit to halt the Trump administration's 340B rebate pilot program.

Hospitals sue to block HHS 340B rebate pilot
Source: healthcaredive.com
Key Evidence
Hospital organizations filed lawsuits to block the federal Department of Health and Human Services from advancing the 340B rebate pilot program.
The legal challenges argued that replacing traditional upfront discounts with a post-sale rebate model violated federal authority.
Plaintiffs including the American Hospital Association sought emergency court intervention such as temporary restraining orders.
What the Evidence Shows
Major hospital associations and nonprofit health systems challenged a federal initiative designed to test a post-sale rebate model instead of traditional upfront discounts for select drugs. Legal filings sought to halt the Department of Health and Human Services and the Health Resources and Services Administration from moving forward with the pilot, arguing that the structure exceeded federal authority.fiercehealthcare.comfiercehealthcare.comHospital Industry Files Lawsuit Block Hhs 340b Rebate Pilot AgainThe claim that hospitals filed lawsuits to halt the Trump administration's 340B rebate pilot program is true, and the hospital industry has engaged in a repeating legal battle over the initiative They contended the program violated the...
triagehealthlawblog.comtriagehealthlawblog.comBack to the Drawing Board Hhs Scraps Initial 340b Rebate Pilot ProgramThe Department of Health and Human Services (HHS) and the Health Resources and Services Administration (HRSA) sought to test a pilot program replacing these upfront discounts with a post-sale rebate model for select drugs They contended...
The American Hospital Association joined regional hospital groups and nonprofit systems to petition the courts for emergency relief, including temporary restraining orders against the testing phase. Industry representatives contended that replacing upfront discounts with a rebate model violated statutory provisions and threatened essential funding streams for safety-net providers.healthcaredive.comhealthcaredive.comHospitals sue to block HHS 340B rebate pilotThe Core Issue: The 340B Drug Pricing Program historically required pharmaceutical manufacturers to sell outpatient drugs to eligible safety-net hospitals and healthcare providers at a discounted price upfront at the point of sale